Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Simioni

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
Thrombosis Research|September 14, 2013
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolismC M Radu, L Spiezia, E Campello, et al.
Thrombosis and Haemostasis|January 30, 2018
Contact System Activation and Cancer: New Insights in the Pathophysiology of Cancer-Associated ThrombosisE Campello, M W Henderson, D F Noubouossie, et al.
Thrombosis and Haemostasis|November 2, 1999
The risk of fetal loss in family members of probands with factor V Leiden mutationD Tormene, P Simioni, P Prandoni, et al.
British Journal of Haematology|February 1, 1996
Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutationP Simioni, L Scarano, S Gavasso, et al.
Minerva Anestesiologica|February 13, 2014
Thromboelastometry for guiding bleeding management of the critically ill patient: a systematic review of the literatureT Haas, K Görlinger, A Grassetto, et al.
International Journal of Laboratory Hematology|September 11, 2012
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosisV Rossetto, L Spiezia, M Senzolo, et al.
British Journal of Haematology|January 14, 1999
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variantP Simioni, D Tormene, D Manfrin, et al.
The Journal of Biological Chemistry|August 15, 1997
Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDENC van 't Veer, M Kalafatis, R M Bertina, et al.
American Journal of Hematology|January 1, 1995
Anticardiolipin antibodies, functional protein S deficiency, and fetal lossA Ruffatti, L DiLenardo, P Simioni, et al.
Blood|June 1, 1989
Partial gene deletion in a family with factor X deficiencyF Bernardi, G Marchetti, P Patracchini, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Thrombosis Research|September 14, 2013
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolismC M Radu, L Spiezia, E Campello, et al.
Thrombosis and Haemostasis|January 30, 2018
Contact System Activation and Cancer: New Insights in the Pathophysiology of Cancer-Associated ThrombosisE Campello, M W Henderson, D F Noubouossie, et al.
Thrombosis and Haemostasis|November 2, 1999
The risk of fetal loss in family members of probands with factor V Leiden mutationD Tormene, P Simioni, P Prandoni, et al.
British Journal of Haematology|February 1, 1996
Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutationP Simioni, L Scarano, S Gavasso, et al.
Minerva Anestesiologica|February 13, 2014
Thromboelastometry for guiding bleeding management of the critically ill patient: a systematic review of the literatureT Haas, K Görlinger, A Grassetto, et al.
International Journal of Laboratory Hematology|September 11, 2012
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosisV Rossetto, L Spiezia, M Senzolo, et al.
British Journal of Haematology|January 14, 1999
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variantP Simioni, D Tormene, D Manfrin, et al.
The Journal of Biological Chemistry|August 15, 1997
Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDENC van 't Veer, M Kalafatis, R M Bertina, et al.
American Journal of Hematology|January 1, 1995
Anticardiolipin antibodies, functional protein S deficiency, and fetal lossA Ruffatti, L DiLenardo, P Simioni, et al.
Blood|June 1, 1989
Partial gene deletion in a family with factor X deficiencyF Bernardi, G Marchetti, P Patracchini, et al.
Pageof 17